A high expression of PD-L1 was commonly observed in HNSCC cells (40–70%) (11, 12), coinciding with the upregulation of PD-1 on the majority of CD8+ tumor-infiltrating lymphocytes (TILs) (11). This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.